Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.53 |
| ▸ | CA1 | P00915 | 5/20 | 0.53 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28630562 | 0.98 | CA2 (0.52) | CA2CA1CPB2MAPK1HDAC1 | |
| SCHEMBL5491480 | 0.96 | CA2 (0.57) | CA2CA1CPB2MAPK1TDP1 | |
| SCHEMBL17435171 | 0.94 | CPB2 (0.51) | CA2CA1CPB2MAPK1HDAC1 | |
| SCHEMBL21052329 | 0.93 | CA2 (0.55) | CA2CA1CPB2MAPK1TDP1 | |
| Hydrochloric Acid SCHEMBL27486062 | 0.93 | CA2 (0.55) | CA2CA1CPB2MAPK1TDP1 | |
| SCHEMBL28301437 | 0.93 | CA2 (0.55) | CA2CA1CPB2MAPK1TDP1 | |
| SCHEMBL9081173 | 0.92 | CPB2 (0.54) | CA2CA1CPB2HDAC1HDAC2 | |
| SCHEMBL29151461 | 0.92 | CPB2 (0.54) | CA2CA1CPB2HDAC1HDAC2 | |
| SCHEMBL28596178 | 0.92 | CPB2 (0.54) | CA2CA1CPB2HDAC1HDAC2 | |
| SCHEMBL28524921 | 0.92 | CPB2 (0.54) | CA2CA1CPB2HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115297861-B | Compounds and uses thereof | 福宏治疗公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-116730832-B | Preparation method of 2-propyl caproic acid | 湖南大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-117897382-A | Nitrogen-containing tricyclic compounds and pharmaceutical uses thereof | 日本烟草产业株式会社 | 2024-04-16 | — | — | CN | disclosed |
| CN-116730832-A | Preparation method of 2-propyl caproic acid | 湖南大学 | 2023-09-12 | — | — | CN | disclosed |
| CN-115385906-A | Method for preparing umeclidinium bromide | 好利安科技有限公司 | 2022-11-25 | — | — | CN | disclosed |
| CN-115297861-A | Compound and use thereof | 福宏治疗公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-112645945-B | Preparation method of Wumei ammonium bromide intermediate | 上海谷森医药有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-114037501-A | Structural recommendation algorithm, device and equipment based on heterogeneous feedback | 深圳大学 | 2022-02-11 | — | — | CN | disclosed |
| CN-113636960-A | Preparation method of 2- (chlorosulfonyl) cyclohexane-1-ethyl olefin formate derivative | 上海皓元医药股份有限公司 | 2021-11-12 | — | — | CN | disclosed |
| CN-112645945-A | Preparation method of Wumei ammonium bromide intermediate | 上海谷森医药有限公司 | 2021-04-13 | — | — | CN | disclosed |
| US-20160015684-A1 | COMPOSITIONS COMPRISING BIOREVERSIBLE DERIVATIVES OF HYDROXY N- SUBSTITUTED-2-AMINOTETRALINS, DOSAGE FORMS, AND RELATED METHODS | SPRIASO LLC | 2016-01-21 | — | — | US | disclosed |
| US-20140309435-A1 | PROCESS FOR PREPARING ESTERS FROM FORMATES AND OLEFINICALLY UNSATURATED COMPOUNDS | EVONIK INDUSTRIES AG (DE) | 2014-10-16 | — | — | US | disclosed |
| US-20140030609-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND ENERGY STORAGE DEVICE USING SAME | UBE INDUSTRIES, LTD. (JP) | 2014-01-30 | — | — | US | disclosed |
| CN-103477492-A | Non-aqueous electrolyte solution and electricity-storage device using same | UBE INDUSTRIES | 2013-12-25 | — | — | CN | disclosed |
| CN-101541754-A | Azabicyclic compounds as monoamine reuptake inhibitors | GLAXO GROUP LTD (GB) | 2009-09-23 | — | — | CN | disclosed |
| EP-1771446-B1 | AZAINDOLE INHIBITORS OF MTP AND APOB | MERCK PATENT GMBH (DE) | 2008-06-11 | — | — | EP | disclosed |
| US-6207739-B1 | Polyamide acid composition containing metal, polyimide film, flexible printed wiring board and method for producing them | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI (JP) | 2001-03-27 | — | — | US | disclosed |
| EP-0629603-B1 | Process for the production of esters | MITSUBISHI GAS CHEMICAL CO (JP) | 1997-10-29 | — | — | EP | disclosed |
| US-5463095-A | Process for the production of esters | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1995-10-31 | — | — | US | disclosed |
| EP-0629603-A1 | Process for the production of esters | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1994-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160015684-A1 | COMPOSITIONS COMPRISING BIOREVERSIBLE DERIVATIVES OF HYDROXY N- SUBSTITUTED-2-AMINOTETRALINS, DOSAGE FORMS, AND RELATED METHODS | SLC7A1, CYP2D6, CYP3A7 | CA2 1820/4885CA1 3239/4885CPB2 634/4885 |
| US-20140309435-A1 | PROCESS FOR PREPARING ESTERS FROM FORMATES AND OLEFINICALLY UNSATURATED COMPOUNDS | FDPS, ELOVL6, ELOVL3 | CA2 3961/4885CA1 3163/4885CPB2 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.